Fresenius (NYSE: FMS) Beats Q2 Profit Estimates, Thanks to Strong Unit Performance and Cost Savings
German healthcare group Fresenius (NYSE: FMS) beat second-quarter operating profit expectations on Wednesday, citing strong performance at its Kabi and […]